Feb 27, 2018
Beacon Discovery announces multi-year GPCR drug discovery collaboration with Takeda focused on gastrointestinal disorders
Feb 02, 2018
Titan Announces Amendment To Horizon Loan Agreement
Jan 31, 2018
Alkermes Submits New Drug Application To U.S. FDA For ALKS 5461 For The Adjunctive Treatment Of Major Depressive Disorder
Jan 22, 2018
Titan In Discussions With Braeburn Regarding U.S. Probuphine® Commercialization
Jan 10, 2018
Braeburn Announces Completion of $110 Million Financing
Jan 04, 2018
Beacon Discovery announces multi-year GPCR-focused drug discovery collaboration with Janssen Pharmaceuticals
Jan 04, 2018
Heptares Scientists Solve Structure of Complement C5a Receptor, an Important Drug Target for Inflammatory and Neurodegenerative Diseases, and Cancer
Jan 03, 2018
Glucagon Receptor Structure Offers New Opportunities for Type 2 Diabetes Drug Discovery
Dec 19, 2017
Confo Therapeutics Enters Into Drug Discovery Collaboration with Roche
Dec 13, 2017
WNT Signaling Pathway Inhibitors Therapeutics Pipeline Analysis 2017: Key Players are Samumed, Can-Fite BioPharma & Tactical Therapeutics
Dec 13, 2017
AbilityPharma Announces FDA Approval of IND for Phase 2 Trial of ABTL0812 in Patients with Endometrial Cancer or Squamous Non-Small Cell Lung Cancer
Dec 11, 2017
Aeonian Pharmaceuticals closes Seed Funding from Apollo Ventures to develop mTORC1 inhibitors
Nov 09, 2017
Titan Pharmaceuticals Reports Third Quarter 2017 Financial Results
Oct 26, 2017
Global Cancer Janus Kinase Inhibitors Market Opportunity & Clinical Trial Insight 2023
Sep 27, 2017
Braeburn Participates in President's Commission Meeting on Combating Drug Addiction and the Opioid Crisis
Sep 20, 2017
Titan Pharmaceuticals To Present At Cantor Fitzgerald Global Healthcare Conference
Sep 19, 2017
BioDelivery Sciences to Present at the Cantor Fitzgerald Global Healthcare Conference and the Ladenburg Thalmann 2017 Healthcare Conference
Aug 31, 2017
Heptares Enters a New Research and Drug Discovery Collaboration Under its 'Orbit' Initiative with Juntendo University
Aug 31, 2017
Mitogen Activated Protein Kinase 1 (ERT1 or MAP Kinase Isoform p42 or Extracellular Signal Regulated Kinase 2 or Mitogen Activated Protein Kinase 2 or MAPK1 or EC 2.7.11.24) - Pipeline Review, H2 2017
Aug 22, 2017
GDC-0084 Progress Update: On Track for Phase II Commencement in 2017